Autek China Inc Cash Flow Conversion Efficiency

Latest as of December 2025: 0.031x

Autek China Inc cash flow conversion efficiency. Based on the latest financial reports, Autek China Inc (300595) has a cash flow conversion efficiency ratio of 0.031x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥170.20 Million ≈ $24.90 Million USD) by net assets (CN¥5.45 Billion ≈ $797.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Autek China Inc (2012–2025)

Cash flow conversion efficiency of Autek China Inc from 2012 to 2025. This chart illustrates how Autek China Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Autek China Inc (300595) stock price for real-time trading data and today's change.

Autek China Inc Cash Flow Conversion Ratio Explained

Autek China Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Autek China Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Autek China Inc ranked by their cash flow conversion efficiency. Also see 300595 market cap overview for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Shenzhen Aisidi Co Ltd
SHE:002416
0.147x
Advantage Oil & Gas Ltd.
TO:AAV
0.048x
Schrodinger Inc
NASDAQ:SDGR
0.194x
Golden Ocean Group Limited
F:KT31
-0.002x
Kernel Holding SA
F:0KE
-0.080x
Zhongmin Energy Co Ltd
SHG:600163
0.012x
CLEARWAY ENERGY A NDL-01
F:NY4B
0.072x
GH Research PLC
NASDAQ:GHRS
-0.042x

Annual Cash Flow Conversion Efficiency for Autek China Inc (2012–2025)

The table below shows the annual cash flow conversion efficiency of Autek China Inc from 2012 to 2025. Review how much free cash does Autek China Inc generate to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥5.45 Billion
≈ $797.38 Million
CN¥827.38 Million
≈ $121.07 Million
0.152x +14.03%
2024-12-31 CN¥5.14 Billion
≈ $752.68 Million
CN¥684.91 Million
≈ $100.22 Million
0.133x -13.28%
2023-12-31 CN¥4.71 Billion
≈ $689.38 Million
CN¥723.38 Million
≈ $105.85 Million
0.154x +8.27%
2022-12-31 CN¥4.60 Billion
≈ $672.46 Million
CN¥651.72 Million
≈ $95.37 Million
0.142x -42.92%
2021-12-31 CN¥2.54 Billion
≈ $371.11 Million
CN¥630.09 Million
≈ $92.20 Million
0.248x +29.87%
2020-12-31 CN¥1.99 Billion
≈ $291.37 Million
CN¥380.94 Million
≈ $55.74 Million
0.191x -0.11%
2019-12-31 CN¥1.44 Billion
≈ $210.40 Million
CN¥275.37 Million
≈ $40.29 Million
0.192x +39.58%
2018-12-31 CN¥1.08 Billion
≈ $158.39 Million
CN¥148.52 Million
≈ $21.73 Million
0.137x -22.98%
2017-12-31 CN¥812.34 Million
≈ $118.87 Million
CN¥144.71 Million
≈ $21.18 Million
0.178x -48.27%
2016-12-31 CN¥315.94 Million
≈ $46.23 Million
CN¥108.80 Million
≈ $15.92 Million
0.344x +8.82%
2015-12-31 CN¥253.53 Million
≈ $37.10 Million
CN¥80.23 Million
≈ $11.74 Million
0.316x -1.81%
2014-12-31 CN¥192.08 Million
≈ $28.11 Million
CN¥61.91 Million
≈ $9.06 Million
0.322x -11.92%
2013-12-31 CN¥145.86 Million
≈ $21.34 Million
CN¥53.37 Million
≈ $7.81 Million
0.366x +100.78%
2012-12-31 CN¥105.24 Million
≈ $15.40 Million
CN¥19.18 Million
≈ $2.81 Million
0.182x --

About Autek China Inc

SHE:300595 China Medical Instruments & Supplies
Market Cap
$1.39 Billion
CN¥9.52 Billion CNY
Market Cap Rank
#7234 Global
#1471 in China
Share Price
CN¥10.63
Change (1 day)
+1.24%
52-Week Range
CN¥9.90 - CN¥17.20
All Time High
CN¥106.29
About

Autek China Inc. engages in the research and development, production, and sale of optometry products and related supporting products in China. The company offers rigid contact lenses, rigid lens care products, myopia control products other than rigid glasses, visual function training products, dry eye/eye strain/presbyopia/accommodative hypoplasia treatment products, and eye health products. It a… Read more